EN | UA
EN | UA

Help Support

Back

NO-NSAIDs represent a valid pharmacological option for post-menopausal osteoporosis

NO-NSAIDs represent a valid pharmacological option for post-menopausal osteoporosis NO-NSAIDs represent a valid pharmacological option for post-menopausal osteoporosis
NO-NSAIDs represent a valid pharmacological option for post-menopausal osteoporosis NO-NSAIDs represent a valid pharmacological option for post-menopausal osteoporosis

What's new?

NO derivatives of NSAIDs safely impacts metabolism of osteoblasts and therefore can be utilized for bone disorders like high-turnover osteoporosis in post-menopausal women.

A recent study published in “Life sciences” journal demonstrated the safer influence of NO-NSAIDs in comparison to Aspirin, Naproxen and Celecoxib. NO-NSAIDs showed inhibitory action towards proteinases which was related to osteoid degradation.

Dr Maria Cristina Aisa and colleagues conducted a study on NO-releasing non-selective NSAIDs. The NSAIDs are the class of drugs best known for their role in alleviating pain and are used post-traumatically/post-operatively to obtain analgesia. However, this class of drugs may restrain repair and remodelling of bones.

 Dr Aisa and colleagues selected two NCX-4016 and HCT-3012, NO-derivatives of Aspirin and Naproxen (NSAIDs) and evaluated their role on osteoblasts in comparison to parent compounds and Celecoxib (COX-2-selective inhibitor). The study involved proliferation, early and late differentiation of MG-63 osteoblast-like cells along with its degradation via proteinases, a necessary step of remodelling). The role of drugs was evaluated at every stage.

 Both NO-NSAIDs did not affect osteoblasts proliferation and differentiation as their parent compounds Aspirin, Naproxen and Cox inhibitor, Celecoxib. Depletion in metalloproteinases, cathepsin B and plasminogen (devastating bone enzymes) activity was observed. Also, the NO-donor sodium nitroprusside showed inhibitory role towards proteinases and reflected positive effect towards bone growth and remodelling.

Source:

Life Sciences

Article:

COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs

Authors:

Maria Cristina Aisa et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: